Morgan Stanley’s Profound Medical PROF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22K | Sell |
3,734
-1,500
| -29% | -$8.85K | ﹤0.01% | 6623 |
|
|
2025
Q1 | $30.5K | Sell |
5,234
-2,555
| -33% | -$14.9K | ﹤0.01% | 6433 |
|
|
2024
Q4 | $58.5K | Buy |
7,789
+3,255
| +72% | +$24.4K | ﹤0.01% | 6240 |
|
|
2024
Q3 | $36.1K | Hold |
4,534
| – | – | ﹤0.01% | 6308 |
|
|
2024
Q2 | $38K | Hold |
4,534
| – | – | ﹤0.01% | 6255 |
|
|
2024
Q1 | $38.7K | Sell |
4,534
-8,488
| -65% | -$72.4K | ﹤0.01% | 6306 |
|
|
2023
Q4 | $111K | Buy |
13,022
+5,288
| +68% | +$44.9K | ﹤0.01% | 6125 |
|
|
2023
Q3 | $78.9K | Buy |
7,734
+1,600
| +26% | +$16.3K | ﹤0.01% | 5987 |
|
|
2023
Q2 | $79.8K | Buy |
6,134
+998
| +19% | +$13K | ﹤0.01% | 6040 |
|
|
2023
Q1 | $47.7K | Sell |
5,136
-1,439
| -22% | -$13.4K | ﹤0.01% | 6307 |
|
|
2022
Q4 | $71.6K | Sell |
6,575
-647
| -9% | -$7.05K | ﹤0.01% | 6129 |
|
|
2022
Q3 | $29K | Buy |
7,222
+375
| +5% | +$1.51K | ﹤0.01% | 6637 |
|
|
2022
Q2 | $50K | Sell |
6,847
-1,172
| -15% | -$8.56K | ﹤0.01% | 6613 |
|
|
2022
Q1 | $72K | Sell |
8,019
-750
| -9% | -$6.73K | ﹤0.01% | 6507 |
|
|
2021
Q4 | $99K | Buy |
8,769
+828
| +10% | +$9.35K | ﹤0.01% | 6442 |
|
|
2021
Q3 | $116K | Sell |
7,941
-21,143
| -73% | -$309K | ﹤0.01% | 6293 |
|
|
2021
Q2 | $476K | Sell |
29,084
-24,379
| -46% | -$399K | ﹤0.01% | 5553 |
|
|
2021
Q1 | $1.08M | Buy |
53,463
+8,893
| +20% | +$179K | ﹤0.01% | 4683 |
|
|
2020
Q4 | $916K | Buy |
44,570
+4,169
| +10% | +$85.7K | ﹤0.01% | 4726 |
|
|
2020
Q3 | $713K | Buy |
40,401
+28,221
| +232% | +$498K | ﹤0.01% | 4441 |
|
|
2020
Q2 | $206K | Sell |
12,180
-1,008
| -8% | -$17K | ﹤0.01% | 5063 |
|
|
2020
Q1 | $129K | Buy |
13,188
+10,128
| +331% | +$99.1K | ﹤0.01% | 5078 |
|
|
2019
Q4 | $33K | Buy |
+3,060
| New | +$33K | ﹤0.01% | 5971 |
|